Literature DB >> 27519927

Effect of Comorbid Knee and Hip Osteoarthritis on Longitudinal Clinical and Health Care Use Outcomes in Older Adults With New Visits for Back Pain.

Sean D Rundell1, Adam P Goode2, Pradeep Suri3, Patrick J Heagerty4, Bryan A Comstock4, Janna L Friedly5, Laura S Gold6, Zoya Bauer6, Andrew L Avins7, Srdjan S Nedeljkovic8, David R Nerenz9, Larry Kessler10, Jeffrey G Jarvik11.   

Abstract

OBJECTIVE: To examine if a comorbid diagnosis of knee or hip osteoarthritis (OA) in older adults with new back pain visits is associated with long-term patient-reported outcomes and back-related health care use.
DESIGN: Prospective cohort study.
SETTING: Three integrated health systems forming the Back pain Outcomes using Longitudinal Data cohort. PARTICIPANTS: Participants (N=5155) were older adults (≥65y) with a new visit for back pain and a complete electronic health record data.
INTERVENTIONS: Not applicable; we obtained OA diagnoses using diagnostic codes in the electronic health record 12 months prior to the new back pain visit. MAIN OUTCOME MEASURES: The Roland-Morris Disability Questionnaire (RDQ) and the EuroQol-5D (EQ-5D) were key patient-reported outcomes. Health care use, measured by relative-value units (RVUs), was summed for the 12 months after the initial visit. We used linear mixed-effects models to model patient-reported outcomes. We also used generalized linear models to test the association between comorbid knee or hip OA and total back-related RVUs.
RESULTS: Of the 5155 participants, 368 (7.1%) had a comorbid knee OA diagnosis, and 94 (1.8%) had a hip OA diagnosis. Of the participants, 4711 (91.4%) had neither knee nor hip OA. In adjusted models, the 12-month RDQ score was 1.23 points higher (95% confidence interval [CI], 0.72-1.74) for patients with knee OA and 1.26 points higher (95% CI, 0.24-2.27) for those with hip OA than those without knee or hip OA, respectively. A lower EQ-5D score was found among participants with knee OA (.02 lower; 95% CI, -.04 to -.01) and hip OA diagnoses (.03 lower; 95% CI, -.05 to -.01) compared with those without knee or hip OA, respectively. Comorbid knee or hip OA was not significantly associated with total 12-month back-related resource use.
CONCLUSIONS: Comorbid knee or hip OA in older adults with a new back pain visit was associated with modestly worse long-term disability and health-related quality of life.
Copyright © 2016 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Back pain; Comorbidity; Osteoarthritis; Patient outcome assessment; Rehabilitation

Mesh:

Year:  2016        PMID: 27519927     DOI: 10.1016/j.apmr.2016.06.022

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  11 in total

1.  Associations of Multiple Chronic Conditions With Physical Performance and Falls Among Older Adults With Back Pain: A Longitudinal, Population-based Study.

Authors:  Sean D Rundell; Amol Karmarkar; Michael Nash; Kushang V Patel
Journal:  Arch Phys Med Rehabil       Date:  2021-04-24       Impact factor: 4.060

2.  What General and Pain-associated Psychological Distress Phenotypes Exist Among Patients with Hip and Knee Osteoarthritis?

Authors:  Trevor A Lentz; Steven Z George; Olivia Manickas-Hill; Morven R Malay; Jonathan O'Donnell; Prakash Jayakumar; William Jiranek; Richard C Mather
Journal:  Clin Orthop Relat Res       Date:  2020-12       Impact factor: 4.755

3.  Associations Between Relative Value Units and Patient-Reported Back Pain and Disability.

Authors:  Laura S Gold; Matthew Bryan; Bryan A Comstock; Brian W Bresnahan; Richard A Deyo; Srdjan S Nedeljkovic; David R Nerenz; Patrick Heagerty; Jeffrey G Jarvik
Journal:  Gerontol Geriatr Med       Date:  2017-01-16

4.  Do medical conditions predispose to the development of chronic back pain? A longitudinal co-twin control study of middle-aged males with 11-year follow-up.

Authors:  Pradeep Suri; Edward J Boyko; Sean D Rundell; Nicholas L Smith; Jack Goldberg
Journal:  BMC Musculoskelet Disord       Date:  2018-10-10       Impact factor: 2.362

5.  Predictors of the analgesic efficacy of pulsed radiofrequency treatment in patients with chronic lumbosacral radicular pain: a retrospective observational study.

Authors:  Seon Ju Kim; Sang Jun Park; Duck Mi Yoon; Kyung Bong Yoon; Shin Hyung Kim
Journal:  J Pain Res       Date:  2018-06-26       Impact factor: 3.133

6.  Global management of patients with knee osteoarthritis begins with quality of life assessment: a systematic review.

Authors:  Marianna Vitaloni; Angie Botto-van Bemden; Rosa Maya Sciortino Contreras; Deborah Scotton; Marco Bibas; Maritza Quintero; Jordi Monfort; Xavier Carné; Francisco de Abajo; Elizabeth Oswald; Maria R Cabot; Marco Matucci; Patrick du Souich; Ingrid Möller; Guy Eakin; Josep Verges
Journal:  BMC Musculoskelet Disord       Date:  2019-10-27       Impact factor: 2.362

7.  Hip osteoarthritis signs and symptoms are associated with increased fall risk among community-dwelling older adults with chronic low back pain: a prospective study.

Authors:  Patrick J Knox; Peter C Coyle; Jenifer M Pugliese; Ryan T Pohlig; Jaclyn M Sions; Gregory E Hicks
Journal:  Arthritis Res Ther       Date:  2021-03-03       Impact factor: 5.156

8.  Methylene blue relieves the development of osteoarthritis by upregulating lncRNA MEG3.

Authors:  Xinyi Li; Chaoliang Tang; Jin Wang; Peipei Guo; Chengyao Wang; Yanlin Wang; Zongze Zhang; Huisheng Wu
Journal:  Exp Ther Med       Date:  2018-03-02       Impact factor: 2.447

9.  Increased risk of knee osteoarthritis in patients using oral N-acetylcysteine: a nationwide cohort study.

Authors:  Ying-Ting Yeh; Chung-Chao Liang; Chia-Ling Chang; Chung-Y Hsu; Pei-Chen Li
Journal:  BMC Musculoskelet Disord       Date:  2020-08-10       Impact factor: 2.362

10.  Factors associated with persistently high-cost health care utilization for musculoskeletal pain.

Authors:  Trevor A Lentz; Jeffrey S Harman; Nicole M Marlow; Jason M Beneciuk; Roger B Fillingim; Steven Z George
Journal:  PLoS One       Date:  2019-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.